Search for: "LITTLE et al v. PFIZER, INC. et al"
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
24 Mar 2016, 4:00 am
Pfizer Inc. et al., 2016 FC 136, that there was no legal basis to invalidate an issued patent due to non-patent of an administrative fee while the application was pending. [read post]
22 Jun 2010, 12:41 pm
Brief in opposition of respondents Independent Living Center of Southern California, Inc. et al. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
4 Aug 2022, 7:54 pm
Pfizer, Inc. v. [read post]
1 Apr 2015, 4:30 am
Target Corp. et al., 2015 Il. [read post]
28 Apr 2008, 11:00 am
(Please accept our apologies that it is a little late this week.) [read post]
23 Jan 2013, 1:02 am
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued October 16, 2012 Decided January 22, 2013 No. 11-1265 AMERICANS FOR SAFE ACCESS, ET AL., PETITIONERS v. [read post]
23 Jan 2013, 1:02 am
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued October 16, 2012 Decided January 22, 2013 No. 11-1265 AMERICANS FOR SAFE ACCESS, ET AL., PETITIONERS v. [read post]
17 May 2011, 10:37 pm
WO 01/08661 to Maloney ("Maloney"), both alone and in combination with United States Patent No. 5,047,248 to Calanchi et al. [read post]
2 Aug 2014, 6:05 am
Niven v. [read post]
13 Jul 2021, 10:58 am
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent… [read post]
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
17 Oct 2021, 2:17 pm
Kehm v. [read post]
